February 24, 2021 -- Bioinformatics provider Seven Bridges has been selected by Pfizer to provide data management services for Pfizer's single-cell RNA sequencing (scRNAseq) data.
The Seven Bridges platform is a cloud-based environment for conducting bioinformatic analyses where teams can store, analyze, and interpret data.
Under the agreement, Seven Bridges will support Pfizer by centralizing and managing terabytes of raw and processed scRNAseq data. These data provide detailed analysis of gene expression in individual cells. But the totality of scRNAseq data can carry a very large footprint. The Seven Bridges platform will provide a cost-effective, secure, end-to-end, scalable, durable, and reliable data storage and management solution for Pfizer.